Testing for Primary Aldosteronism Underutilized Following Stroke: A Multicenter Cohort Study
- 1 February 2026
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 493-498
Abstract
BACKGROUND: Primary aldosteronism, the most common endocrine cause of hypertension, is associated with an increased risk of stroke compared with essential hypertension. Targeted treatment with mineralocorticoid receptor antagonists, or surgical resection of an aldosterone-producing adrenal adenoma, can effectively reduce blood pressure and mitigate cardiovascular risk. However, despite being a highly modifiable cardiovascular risk factor, primary aldosteronism is grossly underdiagnosed, even in high-risk populations. METHODS: We conducted a multicenter retrospective cohort study to assess the frequency of primary aldosteronism testing among patients admitted between January 2019 to January 2020 with stroke or transient ischemic attack. Data, including blood pressure, antihypertensive medication use, serum potassium, and adrenal imaging, were collected from the medical records of patients admitted for stroke or transient ischemic attack at 2 large tertiary hospitals in Victoria, Australia. RESULTS: Among 400 patients (mean age, 73.9±13.4 years; 42.1% female), 30% (n=120) had a clinical indication for primary aldosteronism testing, yet only 2% (n=8) were tested. CONCLUSIONS: These findings highlight a missed opportunity to identify a treatable cause of hypertension in patients at high risk of recurrent cerebrovascular events. Routine testing for primary aldosteronism in stroke care pathways may improve long-term outcomes through targeted intervention.Keywords
This publication has 21 references indexed in Scilit:
- Hypertension in the emergency department: A missed opportunity to screen for primary aldosteronism?Academic Emergency Medicine, 2024
- Screening for primary aldosteronism is underutilised in patients with chronic kidney diseaseJournal Of Nephrology, 2022
- Screening for primary aldosteronism in the diabetic population: a cohort studyInternal Medicine Journal, 2022
- Primary Aldosteronism in Patients in China With Recently Detected HypertensionJACC, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort studyThe Lancet Diabetes & Endocrinology, 2018
- Cardiovascular Complications Associated With Primary AldosteronismHypertension, 2013
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Evidence for an increased rate of cardiovascular events in patients with primary aldosteronismJACC, 2005